|
Q1 FY2017
As of Dec 31, 2016
|
Q4 FY2016
As of Sep 30, 2016
|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
Q3 FY2015
As of Jun 30, 2015
|
Q2 FY2015
As of Mar 31, 2015
|
Q1 FY2015
As of Dec 31, 2014
|
Q4 FY2014
As of Sep 30, 2014
|
Q3 FY2014
As of Jun 30, 2014
|
Q2 FY2014
As of Mar 31, 2014
|
Q1 FY2014
As of Dec 31, 2013
|
Q4 FY2013
As of Sep 30, 2013
|
Q3 FY2013
As of Jun 30, 2013
|
Q2 FY2013
As of Mar 31, 2013
|
Q1 FY2013
As of Dec 31, 2012
|
Q4 FY2012
As of Sep 30, 2012
|
Q3 FY2012
As of Jun 30, 2012
|
Q2 FY2012
As of Mar 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash & cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Note receivable, net of allowance for uncollectable accounts of $52,347 | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Deferred loan fees | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued compensation and related expenses | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Notes payable and accrued interest, net of discount of $58,948 and $13,258, respectively | ||||||||||||||||||||
| Notes payable and accrued interest, net of discount of $178,807 and $45,775 respectively | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long term liabilities | ||||||||||||||||||||
| Notes payable and accrued interest, net of discount of $0 and $202,857, respectively | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' deficit | ||||||||||||||||||||
| Preferred stock $0.001par value: 5,000,000 shares authorized Series B convertible: 2,222,022 shares designated, 1,222,236 shares issued and outstanding | ||||||||||||||||||||
| Total preferred stock $0.001par value: 5,000,000 shares authorized Series B convertible: 2,222,022 shares designated, 1,222,236 shares issued and outstanding | ||||||||||||||||||||
| Common stock $0.001 par value, 5,400,000,000 shares authorized 2,596,508,421 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||||||
| Total liabilities and stockholders' deficit | ||||||||||||||||||||
Loading...
